GlassScriptPhysician profile
Swathi Beeravolu
NPI 1396051819
$9,291.14
in general payments reported to CMS, 2019-2025
53 companies · $2,417 in 2025
The $2,417 reported for 2025 was more than what 80% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,361 · 2020: $509 · 2022: $1,402 · 2023: $1,680 · 2024: $1,922 · 2025: $2,417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,019.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,019.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,018.64 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Insulet Corporation | $766.39 | 2019-2025 | Omnipod |
| Amgen INC. | $679.22 | 2019-2025 | Evenity, Prolia, Tepezza |
| Novo Nordisk INC | $482.56 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Sanofi-Aventis U.S. LLC | $458.78 | 2019-2025 | |
| Dexcom, INC. | $379.46 | 2019-2025 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $353.59 | 2022-2025 | Gvoke Hypopen, Recorlev |
| Tandem Diabetes Care, INC. | $349.33 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Corcept Therapeutics | $327.24 | 2019-2025 | Korlym |
| Medtronic, INC. | $320.63 | 2023-2025 | Minimed 780g, Intellis Adaptivestim |
| Alexion Pharmaceuticals, INC. | $288.39 | 2022-2025 | Strensiq |
| Abbott Laboratories | $274.98 | 2019-2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $263.15 | 2019-2025 | Farxiga |
| Abbvie INC. | $245.23 | 2019-2025 | Synthroid |
| Cequr Corporation | $226.23 | 2022-2025 | Cequr Simplicity |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $225.21 | 2019-2025 | Tirosint, Licart, Licart |
| Sequel Med Tech, LLC | $188.34 | 2025 | Twiist |
| Boehringer Ingelheim Pharmaceuticals, INC. | $185.10 | 2019-2025 | Jardiance |
| Beta Bionics, INC. | $172.42 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Kyowa Kirin, INC. | $171.78 | 2023-2025 | Crysvita |
| Amneal Pharmaceuticals LLC | $160.87 | 2019-2025 | Unithroid |
| Valeritas, INC. | $125.94 | 2019 | |
| Antares Pharma, INC. | $124.25 | 2019-2024 | Xyosted, Tlando, Nocdurna |
| Ascensia Diabetes Care US INC. | $108.91 | 2024-2025 | |
| Recordati_rare_diseases_inc. | $102.15 | 2022-2025 | Isturisa, Signifor Lar |
| Neurocrine Biosciences, INC. | $96.08 | 2024-2025 | |
| Lifescan, INC. | $91.45 | 2019-2022 | |
| Madrigal Pharmaceuticals | $90.57 | 2024-2025 | Rezdiffra, Resmetirom |
| Merck Sharp & Dohme LLC | $88.42 | 2019-2022 | |
| Radius Health, INC. | $80.89 | 2020-2025 | Tymlos |
| Rhythm Pharmaceuticals, INC. | $68.11 | 2024-2025 | Imcivree |
| Janssen Pharmaceuticals, INC | $68.06 | 2019-2020 | |
| Horizon Therapeutics Plc | $64.07 | 2020-2022 | |
| Shire North American Group INC | $57.50 | 2019 | |
| Almatica Pharma LLC | $51.61 | 2025 | Teriparatide |
| Becton, Dickinson and Company | $50.90 | 2019-2022 | |
| Amryt Pharma Holdings LTD | $48.68 | 2023 | Mycapssa |
| Mannkind Corporation | $47.55 | 2019-2023 | Afrezza |
| Novartis Pharmaceuticals Corporation | $46.96 | 2023 | |
| Chiesi USA, INC. | $43.97 | 2025 | Mycapssa, Myalept |
| Amphastar Pharmaceuticals, INC. | $39.86 | 2024 | Baqsimi |
| Ascendis Pharma Endocrinology INC | $39.47 | 2025 | Yorvipath |
| Halozyme INC | $26.83 | 2023 | |
| Verity Pharmaceuticals INC. | $25.57 | 2025 | Tlando |
| Embecta Corp. | $24.75 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Ultragenyx Pharmaceutical INC. | $24.46 | 2022 | |
| Companion Medical, INC. | $19.78 | 2019 | |
| Amarin Pharma, INC. | $19.72 | 2022 | |
| Zealand Pharma US, INC. | $19.38 | 2022 | |
| Esperion Therapeutics, INC. | $18.97 | 2024 | Nexletol |
| Senseonics, Incorporated | $14.00 | 2019 | |
| Medtronic Minimed, INC. | $12.76 | 2019 | |
| Eusa Pharma (US) LLC | $11.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Swathi Beeravolu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.